QR code

Metformin Impedes Oxidation of LDL In Vitro

Metformin is the most commonly prescribed glucose-lowering drug for the treatment of type 2 diabetes. The aim of this study was to investigate whether metformin is capable of impeding the oxidation of LDL, a crucial step in the development of endothelial dysfunction and atherosclerosis. LDL was oxid...

Volledige beschrijving

Bewaard in:
Hoofdauteurs: Christine Rossmann, Cornelia Ranz, Gerd Kager, Gerhard Ledinski, Martin Koestenberger, Willibald Wonisch, Thomas Wagner, Sebastian P. Schwaminger, Bruno Di Geronimo, Andelko Hrzenjak, Seth Hallstöm, Gilbert Reibnegger, Gerhard Cvirn, Margret Paar
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2023-08-01
Reeks:Pharmaceutics
Onderwerpen:
antioxidants
atherosclerosis
diabetes
copper ions
low density lipoprotein
lipid oxidation
Online toegang:https://www.mdpi.com/1999-4923/15/8/2111
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items